Calcipotrioldid did not have a strong inhibitory effect on IL-23/IL-17A axis-induced inflammation, which was consistent with our finding that Calcipotriol did not significantly inhibit IL-17A and IL-23, demonstrating that Calcipotriol was not suitable for the treatment of IMQ-induced psoriasis-like mice. This evidence concerns the gene IL17A and psoriasis.